Diabetes Drug Reduces Acute GVHD After Stem Cell Transplant ...Middle East

Adding the diabetes drug sitaliptin to immunosuppression therapies for patients undergoing stem cell transplant reduced the risk of developing acute graft-vs-host disease (GVHD). Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Diabetes Drug Reduces Acute GVHD After Stem Cell Transplant )

Also on site :

• Japan starts deploying Osprey fleet at a new base to beef up southwestern defense
• South Africa seeks US trade deal after Trump’s 30% citrus tariff
• Josh O’Connor Goes Full Cowboy in ‘Rebuilding’ as Director Max Walker-Silverman Takes on Life After the Fires: ‘Loss Often Comes With Love’